HIV
News
-
CTN+ at CAHR 2026: Overcoming Challenges
Every year, scientists from across the country gather for Canadian Conference on HIV/AIDS Research (CAHR). This year it…
-
Postdoc Spotlight: Paolo Palma
Dr. Paolo Palma joined the CTN+ in 2025 as a postdoctoral fellow. Grounded by a background in social…
-
The Toronto Patient: New HIV prolonged remission and possible cure case reported
Today, the HIV research community is one step closer to finding a cure. In a Canadian first, a…
-
Seeking Relief: The realities of living with HIV and chronic pain
Picture this: You wake up in the morning already sore. Pain shoots down your leg as soon as…
-
Envisioning the future: What should an HIV cure look like?
Modern HIV medications are powerful in both managing the infection and preventing its transmission and many of its…
-
Prevention strategies for all: Launch of the 2025 Canadian HIV PEP & PrEP Guideline
Led by Dr. Darrell Tan and supported by the CTN+, this document provides the most update-to-date evidence for…
-
How small changes are making big strides in prison harm reduction
One in four people in Canadian federal prisons have been previously exposed to hepatitis C. Hepatitis C can…
-
Welcoming the 2025 Cohort of CTN+ Postdoctoral Fellows
The CTN+ is dedicated to supporting HIV and STBBI research across Canada, and a crucial part of that…
-
Postdoc Spotlight: Hajar Miranzadeh
Hajar Miranzadeh moved to Canada in 2015 to start her PhD in Pharmacology at the University of Saskatchewan.…
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
There are no results message
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTN 345: RESTART Trial
REducing SysTemic inflammation for people on AntiRetroviral Therapy
-
CTNPT 055: Testing Immunogenicity and Durability of Mpox Vaccination in People Living with HIV
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
-
CTN 343: Project ReportNeedles.ca
Project ReportNeedles.ca: A rapid assessment and response system to map needle prevalence and implement harm reduction interventions in Regina, Saskatchewan
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.